Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 1467 entries
View as:

Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term)

Phase: N/A Priority: Normal
NCT ID: NCT01507831 Org: User:
Start: 01/31/12 End: 11/30/14 Due: 11/30/15

Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China

Phase: N/A Priority: Normal
NCT ID: NCT03001011 Org: User:
Start: 06/07/17 End: 08/16/19 Due: 08/16/20

MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00275210 Org: User:
Start: 10/31/98 End: 04/30/03 Due: 04/30/04

Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin

Phase: N/A Priority: Normal
NCT ID: NCT02584504 Org: User:
Start: 11/30/15 End: 01/09/18 Due: 01/09/19

Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00432614 Org: User:
Start: 01/31/07 End: 02/29/08 Due: 02/28/09

Study of Weight-Reducing Effect and Safety of Rimonabant In Obesity in ASIA (RIO-ASIA)

Phase: N/A Priority: Normal
NCT ID: NCT00325546 Org: User:
Start: 04/30/06 End: 04/30/07 Due: 04/30/08

Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)

Phase: N/A Priority: Normal
NCT ID: NCT00067093 Org: User:
Start: 05/31/03 End: 09/30/05 Due: 09/30/06

Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra®) in Subjects Aged 6 to 35 Months

Phase: N/A Priority: Normal
NCT ID: NCT05832333 Org: User:
Start: 10/05/19 End: 02/07/22 Due: 02/07/23

Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00616694 Org: User:
Start: 07/31/02 End: 12/31/04 Due: 12/31/05

A Study of Isatuximab-based Therapy in Participants With Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03769181 Org: User:
Start: 12/11/18 End: 11/08/22 Due: 11/08/23

Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02999633 Org: User:
Start: 03/08/17 End: 11/14/17 Due: 11/14/18

Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02027753 Org: User:
Start: 12/31/13 End: 04/30/15 Due: 04/30/16

Oxaliplatin in Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00259363 Org: User:
Start: 10/31/02 End: - Due: -

Taxotere Prostate Cancer New Indication Registration Trial in China

Phase: N/A Priority: Normal
NCT ID: NCT00436839 Org: User:
Start: 01/31/07 End: 06/30/12 Due: 06/30/13

First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01156870 Org: User:
Start: 09/08/10 End: 04/07/17 Due: 04/07/18

Practicability and Acceptability of Stylomax® in Children

Phase: N/A Priority: Normal
NCT ID: NCT00476385 Org: User:
Start: 06/30/03 End: - Due: -

Dermacyd Delicata Pocket BR - Photo Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT00668226 Org: User:
Start: 12/31/07 End: - Due: -

Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)

Phase: N/A Priority: Normal
NCT ID: NCT01212913 Org: User:
Start: 08/31/10 End: 05/31/12 Due: 05/31/13

Comparison of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties

Phase: N/A Priority: Normal
NCT ID: NCT00788515 Org: User:
Start: 11/30/08 End: 01/31/09 Due: 01/31/10

Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04349306 Org: User:
Start: 05/14/20 End: 03/12/21 Due: 03/12/22

HUPS: Hyalgan Use in Painful Shoulder

Phase: N/A Priority: Normal
NCT ID: NCT00377624 Org: User:
Start: 01/31/02 End: 09/30/04 Due: 09/30/05

Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites

Phase: N/A Priority: Normal
NCT ID: NCT00501566 Org: User:
Start: 04/30/04 End: 01/31/05 Due: 01/31/06

A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.

Phase: N/A Priority: Normal
NCT ID: NCT06850051 Org: User:
Start: 03/19/25 End: 10/31/25 Due: 10/31/26

A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01107756 Org: User:
Start: 03/31/10 End: 07/31/12 Due: 07/31/13

Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses

Phase: N/A Priority: Normal
NCT ID: NCT01487096 Org: User:
Start: 04/30/01 End: 03/31/03 Due: 03/31/04